Sort by
Refine Your Search
-
Listed
-
Category
-
Field
-
Biology, Biochemistry, Life Science, (Bio-)Physics, Chemistry, Computer Science, or related fields. Visit the IMPRS-LM website for more information about the program, the application process , and the
-
of membrane electrode assembly for fuel cell Your profile Completed university studies (Master/Diploma) in the field of Mechanical Engineering, Process Engineering, Chemistry, Physics or related field Very good
-
Science, Physics, Materials Engineering, Nuclear Engineering, or a related field Solid knowledge of microstructural and mechanical characterization of materials, ideally with experience in TEM/STEM and
-
for this purpose. Without these declarations we cannot consider or process your application and will immediately delete any application documents already received after the application deadline. Please include a
-
strong background in the physical sciences who are intensely interested in biosciences. Physicists, biophysicists, and polymer scientists, as well as physical chemists with a strong computational
-
/NL. The successful candidates commit to actively participate in networking including regular research visits to the partner laboratories. Requirements: university degree in chemistry or physics and
-
Areas of study Neuroscience, Physics, Applied Computer Science, Bioinformatics, Computer Science, Engineering Informatics, Medical Informatics, Chemistry, Analytical Chemistry, Inorganic Chemistry
-
month Your profile Excellent master’s degree in physics, materials science, engineering or chemistry Very good English knowledge We are committed to employing more handicapped individuals and especially
-
, dissertation) Your profile University degree (Master’s or Diploma) in Materials Science, Physics, Materials Engineering, Nuclear Engineering, or a related field Solid knowledge of materials characterization
-
this process: How are mRNAs discriminated against all other nuclear RNAs? How does the cell ensure that only fully matured mRNAs are exported? How are faulty mRNAs and transcription byproducts targeted